Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0350 Transporter Info | ||||
Gene Name | SLC39A9 | ||||
Transporter Name | Zinc transporter ZIP9 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Zinc Acetate co-treated with motexafin gadolinium results in increased expression of SLC39A9 mRNA | [1] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Valproic Acid affects the expression of SLC39A9 mRNA | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
SLC39A9 protein results in increased transport of Zinc | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide inhibits the reaction Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in decreased expression of SLC39A9 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acrolein |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
alpha-pinene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-lapachone |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-lapachone results in decreased expression of SLC39A9 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
beta-lapachone results in increased expression of SLC39A9 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased expression of SLC39A9 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
di-n-butylphosphoric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
di-n-butylphosphoric acid affects the expression of SLC39A9 mRNA | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
K 7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
K 7174 results in increased expression of SLC39A9 mRNA | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Lactic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Lactic Acid results in decreased expression of SLC39A9 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methacrylaldehyde |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
motexafin gadolinium |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
motexafin gadolinium results in increased expression of SLC39A9 mRNA | [1] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Zinc Acetate co-treated with motexafin gadolinium results in increased expression of SLC39A9 mRNA | [1] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Ozone |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Volatile Organic Compounds co-treated with Ozone results in increased expression of SLC39A9 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
prochloraz |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
prochloraz inhibits the reaction Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased expression of SLC39A9 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Sodium Selenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sodium Selenite results in increased expression of SLC39A9 mRNA | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Testosterone |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide inhibits the reaction Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
prochloraz inhibits the reaction Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
vinclozolin inhibits the reaction Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
vinclozolin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
vinclozolin inhibits the reaction Testosterone binds to SLC39A9 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Mycotoxins |
|||||
ochratoxin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
ochratoxin A results in decreased expression of SLC39A9 mRNA | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Zinc Acetate |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zinc Acetate increases the expression of SLC39A9 | [1] | |||
Theophylline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Theophylline increases the expression of SLC39A9 | [2] | |||
Hydrogen Peroxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Hydrogen Peroxide affects the expression of SLC39A9 | [3] | |||
Calcitriol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Calcitriol inhibits the expression of SLC39A9 | [4] | |||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zidovudine increases the expression of SLC39A9 | [5] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Doxorubicin inhibits the expression of SLC39A9 | [6] | |||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid increases the expression of SLC39A9 | [7] | |||
Drug in Phase 2 Trial |
|||||
Motexafin gadolinium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Motexafin gadolinium increases the expression of SLC39A9 | [1] | |||
Investigative Drug |
|||||
Milchsaure |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Milchsaure inhibits the expression of SLC39A9 | [14] | |||
Patented Pharmaceutical Agent |
|||||
K-7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
K-7174 increases the expression of SLC39A9 | [12] | |||
Natural Product |
|||||
Particulate Matter |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Particulate Matter inhibits the expression of SLC39A9 | [13] | |||
Resveratrol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Plant Extracts co-treated with Resveratrol results in increased expression of SLC39A9 mRNA | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Plant Extract |
|||||
Grape Seed Proanthocyanidins |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Grape Seed Proanthocyanidins increases the expression of SLC39A9 | [11] | |||
Environmental toxicant |
|||||
Zinc |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zinc inhibits the expression of SLC39A9 | [8] | |||
Lead |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Lead results in increased expression of SLC39A9 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acute Toxic Substance |
|||||
Ochratoxin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Ochratoxin A inhibits the expression of SLC39A9 | [9] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene increases the expression of SLC39A9 | [10] | |||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Arsenic affects the methylation of SLC39A9 gene | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.